INSIGHTS ON SOLID DOSE MANUFACTURING
-
Seizing Market Share Pre-Patent Expiry: The Evolution Of A CDMO Partnership In Navigating A Paragraph IV ANDA Submission
The dynamic pharmaceutical landscape demands agility and strategic foresight. Explore how leveraging a key partnership helped to overcome a looming patent expiry for a second-generation acne medication.
-
NanoImprove The Performance Of Your Formulations
Learn how Nanoforming can help improve the performance of your molecule by increasing drug loads, improving bioavailability, enhancing drug delivery profiles, and supporting product differentiation.
-
How High Drug Load Nanocrystalline Tablets Lower Pill Burden
We showcase the development of high drug load nanocrystal based tablets and prove that nanocrystals can match the pharmacokinetic performance of ASDs while reducing the overall pill burden.
-
Developing And Manufacturing Minitablets To Extend Drug Lifecycle
Pharmaceutical companies should leverage oral minitablets to extend drug lifecycles, optimize dosing, and improve patient-centric solutions while overcoming manufacturing challenges.
-
Taste-Masked Dosage Forms For Pediatric Oral Delivery: An Industrial Perspective7/18/2024
Leveraging strategies and technologies for pediatric patient compliance for taste masking and controlled release in pharmaceutical products, enables flexibility in dosage and format options.
-
FastLok⢠Die Table Surface Overview10/8/2025
Learn about a toolless, removable surface that allows for rapid, on-turret plate replacement in minutes, not weeks, significantly improving operational efficiency.
-
Closing The Duration Gap In FDA-Approved Long-Acting Contraceptives7/17/2024
A gap exists between three months and three years in FDA-approved long-acting contraceptives (LACs). A microsphere formulation enables sustained release over a six to twelve-month period.
-
Technologies And Patient-Centric Solutions7/18/2024
Our innovative technology platforms, including Taste Masked Microcaps® and Optimµm®, address issues like taste masking, swallowability, and controlled release to improve patients' quality of life.
-
Advancing Patient-Centric Drug Delivery For Neurodegenerative Disease With Orally Dissolving Tablets1/27/2025
Pharmaceutical companies must prioritize patient-centric dosage forms to address challenges like dysphagia, enhance medication compliance, and improve therapeutic outcomes.
SOLID DOSE MANUFACTURING SOLUTIONS
-
Containment is a major concern for GMP industries. With a proven track record in managing highly technical and challenging isolation projects Dec is the perfect partner for the integration of new or existing equipment by providing comprehensive safe, ergonomic and dedicated containment solutions.
-
Used Glatt GPCG2 LabSystem Fluid Bed Dryer, 200-460V, 50/60Hz, 3 PH, serial# 79589, built 2013.
-
Used IMA Zanasi 6 F Capsule Filler, rated up to 6000 capsules/hour, no change parts, capable of producing 00-5 size capsules, with controls and Siemens PLC, 230 volt, 3 phase, serial# 35071, built 2006.
-
Used Korsch rotary tablet press, model PH250/25, 25 station, 20 Kn pre compression, 80 Kn main compression, 16 mm max tablet diameter, 18 mm max depth of fill, single side with force feeder, rated up to 180000 tablets/hour, serial# 1.0031.94, built 1994.
-
Ropack Pharma Solution’s ample, nimble capacity and validated processes bring quality and reliability to encapsulation.